Transcriptional analyses represent a powerful ... Similarly, the recently identified novel CDK inhibitors SIM and EL2 are likely candidates to arrest the cell cycle, both in response to ...
Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the treatment of breast cancer to Roche's Genentech for an upfront cash ...
Joan Massagué, PhD, a world leader in research on signaling pathways and transcriptional programs that regulate normal cell behavior ... He provided a direct explanation for how external signals block ...